David Young - Net Worth and Insider Trading
David Young Net Worth
The estimated net worth of David Young is at least $66,111 dollars as of 2025-04-13. David Young is the Pres. Research & Development of Processa Pharmaceuticals Inc and owns about 265,720 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $66,111. Details can be seen in David Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Young has not made any transactions after 2025-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Young
David Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Young owns 1 companies in total, including Processa Pharmaceuticals Inc (PCSA) .
Click here to see the complete history of David Young’s form 4 insider trades.
Insider Ownership Summary of David Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2025-01-27 | director & 10 percent owner & President & CEO |
David Young Latest Holdings Summary
David Young currently owns a total of 1 stock. David Young owns 265,720 shares of Processa Pharmaceuticals Inc (PCSA) as of January 27, 2025, with a value of $66,111.
Latest Holdings of David Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2025-01-27 | 265,720 | 0.25 | 66,111 |
Holding Weightings of David Young
David Young Form 4 Trading Tracker
According to the SEC Form 4 filings, David Young has made a total of 7 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 124,500 shares on January 27, 2025, which cost David Young around $99,600.
Insider Trading History of David Young
- 1
David Young Trading Performance
GuruFocus tracks the stock performance after each of David Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Young is -8.22%. GuruFocus also compares David Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Young within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Young's insider trading performs compared to the benchmark.
Performance of David Young
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.14 | | | | | |
| Relative Return to S&P 500(%) | -1.57 | | | | | |
David Young Ownership Network
Ownership Network List of David Young
Ownership Network Relation of David Young
David Young Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
David Young is the director & 10 percent owner & President & CEO of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include Chief Executive Officer George K Ng , Chief Business - Strategy Off Patrick Lin , and Chief Administrative Officer Wendy Guy .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, David Young made 3 insider transaction in Processa Pharmaceuticals Inc (PCSA) with a net purchase of 165,500. Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 97,200 shares made by George K Ng , a net purchase of 47,500 shares made by Patrick Lin , and a net purchase of 20,400 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 267,600 shares, with a net purchase of 267,600 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 330,600 shares were bought by its insiders, resulting in a net purchase of 330,600 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
David Young Mailing Address
Above is the net worth, insider trading, and ownership report for David Young. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Young's mailing address is: Columbia Md 21045.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
